Pearl River Capital’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,852
Closed -$546K 302
2024
Q2
$546K Buy
+2,852
New +$579K 0.09% 268
2023
Q3
Sell
-2,858
Closed -$624K 592
2023
Q2
$624K Buy
+2,858
New +$637K 0.1% 280
2022
Q2
Sell
-1,844
Closed -$447K 548
2022
Q1
$447K Sell
1,844
-3,154
-63% -$763K 0.12% 248
2021
Q4
$1.3M Buy
4,998
+656
+15% +$170K 0.35% 84
2021
Q3
$1.14M Buy
+4,342
New +$1.19M 0.31% 103
2021
Q2
Sell
-6,031
Closed -$1.17M 553
2021
Q1
$1.17M Buy
6,031
+2,510
+71% +$503K 0.37% 74
2020
Q4
$748K Sell
3,521
-3,948
-53% -$787K 0.27% 129
2020
Q3
$1.28M Buy
+7,469
New +$1.38M 0.54% 47

Other funds holding RMD

Pearl River Capital's RMD Position: Q3 2024 in Review

Pearl River Capital sold out of ResMed (RMD) in Q3 2024, closing a stake of 2,852 shares — an estimated $546K sold.

Pearl River Capital first reported a position in RMD in Q3 2020 and held it in 8 quarters. The position peaked at $1.3M in Q4 2021. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Pearl River Capital reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • Pearl River Capital sold 2,852 ResMed shares in Q3 2024, an estimated $546K.
  • Pearl River Capital first reported a position in ResMed in Q3 2020 and held it in 8 quarters.
  • Pearl River Capital's ResMed position peaked at $1.3M in Q4 2021.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Pearl River Capital's 13F filing for Q3 2024.